Demystifying Insmed: Insights From 7 Analyst Reviews
Demystifying Insmed: Insights From 7 Analyst Reviews
揭開insmed的神祕面紗：來自7位分析師的見解
A clear picture of Insmed's perception among...Throughout the last three months, 7 analysts have evaluated Insmed (NASDAQ:INSM), offering a diverse set of opinions from bullish to bearish.
在過去三個月中，7位分析師對insmed（納斯達克:INSM）進行了評估，提供了從看好到看淡的多樣化觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $89.71, a high estimate of $105.00, and a low estimate of $74.00. This upward trend is evident, with the current average reflecting a 5.54% increase from the previous average price target of $85.00.
分析師評估的12個月價格目標顯示了進一步的見解，平均目標爲89.71美元，高估計爲105.00美元，低估計爲74.00美元。這個上升趨勢顯而易見，目前的平均值反映出比之前85.00美元的平均價格目標增加了5.54%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
A clear picture of Insmed's perception among...
對insmed在...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間